These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27440781)

  • 1. The role of prostate inflammation and fibrosis in lower urinary tract symptoms.
    Bushman WA; Jerde TJ
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F817-F821. PubMed ID: 27440781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of prostate peripheral zone thickness with benign prostatic hyperplasia/ lower urinary tract symptoms: An update].
    Kong B; Hou X; Yang JY
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):744-748. PubMed ID: 32227720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
    Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS.
    Vignozzi L; Gacci M; Cellai I; Morelli A; Maneschi E; Comeglio P; Santi R; Filippi S; Sebastianelli A; Nesi G; Serni S; Carini M; Maggi M
    Prostate; 2013 Sep; 73(13):1391-402. PubMed ID: 23765639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts.
    Lee CL; Kuo HC
    Ci Ji Yi Xue Za Zhi; 2017; 29(2):79-83. PubMed ID: 28757771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic fibrosis: Progress in studies].
    Zhang JC; Zhao F; Duan Y
    Zhonghua Nan Ke Xue; 2020 Jan; 26(1):83-87. PubMed ID: 33345483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic inflammation and collagen content are not positively correlated in human BPH.
    Schneider AJ; Serrell EC; Grimes M; Wang S; Bushman W
    Prostate; 2023 Dec; 83(16):1529-1536. PubMed ID: 37602498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic fibrosis, lower urinary tract symptoms, and BPH.
    Rodriguez-Nieves JA; Macoska JA
    Nat Rev Urol; 2013 Sep; 10(9):546-50. PubMed ID: 23857178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
    Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
    Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
    Silva J; Silva CM; Cruz F
    Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia.
    Lee CL; Kuo HC
    Ci Ji Yi Xue Za Zhi; 2017; 29(1):6-11. PubMed ID: 28757757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines and BPH/LUTS.
    Macoska JA
    Differentiation; 2011; 82(4-5):253-60. PubMed ID: 21600689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling.
    Rodríguez-Nieves JA; Patalano SC; Almanza D; Gharaee-Kermani M; Macoska JA
    PLoS One; 2016; 11(7):e0159490. PubMed ID: 27434301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol reduces inflammation-related Prostate Fibrosis.
    Vicari E; Arancio A; Catania VE; Vicari BO; Sidoti G; Castiglione R; Malaguarnera M
    Int J Med Sci; 2020; 17(13):1864-1870. PubMed ID: 32788865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia.
    Adrian AE; Liu TT; Pascal LE; Bauer SR; DeFranco DB; Ricke WA
    J Gerontol A Biol Sci Med Sci; 2024 Jun; 79(6):. PubMed ID: 37738211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.